Biotech ETFs Could Heat Up Thanks to Republican-Led Congress

Markets ETF Trends

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, and the rival SPDR S&P Biotech ETF (NYSEArca: XBI) are performing well this year. Underscoring that point, the two widely followed biotech ETFs are up an average of 20.5% year-to-date and some traders believe biotechnology stocks and ETFs will continue…Click to read more at ETFtrends.com.

Continue Reading Below